전일 마감가:
$119.05
열려 있는:
$118.81
하루 거래량:
1.34M
Relative Volume:
1.59
시가총액:
$8.58B
수익:
$12.82B
순이익/손실:
$936.34M
주가수익비율:
11.17
EPS:
10.74
순현금흐름:
$1.47B
1주 성능:
-7.44%
1개월 성능:
-8.53%
6개월 성능:
-14.99%
1년 성능:
-17.23%
다비타 Stock (DVA) Company Profile
명칭
Davita Inc
전화
310-536-2668
주소
2000 16TH STREET, DENVER, CO
DVA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
DVA
Davita Inc
|
119.97 | 8.40B | 12.82B | 936.34M | 1.47B | 10.74 |
|
HCA
Hca Healthcare Inc
|
471.68 | 105.33B | 74.37B | 7.31B | 8.10B | 25.88 |
|
THC
Tenet Healthcare Corp
|
207.73 | 17.70B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
24.29 | 15.46B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
UHS
Universal Health Services Inc
|
224.19 | 14.05B | 16.08B | 1.20B | 1.06B | 17.82 |
|
EHC
Encompass Health Corp
|
117.14 | 11.68B | 5.51B | 494.70M | 386.40M | 4.84 |
다비타 Stock (DVA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-03-06 | 개시 | Barclays | Equal Weight |
| 2023-08-07 | 업그레이드 | UBS | Neutral → Buy |
| 2022-11-01 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-10-31 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-08-19 | 재개 | UBS | Buy |
| 2022-06-21 | 재확인 | BofA Securities | Underperform |
| 2021-09-10 | 개시 | Cowen | Market Perform |
| 2021-08-12 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2021-03-26 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2021-01-05 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-01-24 | 업그레이드 | Goldman | Neutral → Buy |
| 2019-11-07 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | 업그레이드 | UBS | Sell → Neutral |
| 2019-01-03 | 개시 | Deutsche Bank | Buy |
| 2018-12-14 | 개시 | Barclays | Overweight |
| 2018-11-28 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | 개시 | UBS | Sell |
| 2018-11-08 | 다운그레이드 | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2018-01-04 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2017-12-07 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2017-06-26 | 다운그레이드 | Jefferies | Buy → Hold |
| 2016-12-13 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
모두보기
다비타 주식(DVA)의 최신 뉴스
TD Cowen Lowers DaVita (NYSE:DVA) Price Target to $133.00 - MarketBeat
DaVita Marks 25 Years of Innovation with Breakthrough Kidney Care Research at ASN Kidney Week 2025 - PR Newswire
Using AI based signals to follow DaVita Inc.Global Markets & Community Shared Stock Ideas - newser.com
Has DaVita Inc. formed a bullish divergenceWeekly Trend Summary & Weekly Top Gainers Alerts - newser.com
Technical analysis overview for DaVita Inc. stock2025 Top Decliners & Daily Profit Focused Stock Screening - newser.com
iA Global Asset Management Inc. Sells 6,594 Shares of DaVita Inc. $DVA - MarketBeat
Y Intercept Hong Kong Ltd Takes $1.24 Million Position in DaVita Inc. $DVA - MarketBeat
Can DaVita Inc. (TRL) stock retain market dominanceJuly 2025 Update & Weekly Stock Breakout Alerts - newser.com
Sentiment analysis tools applied to DaVita Inc.July 2025 News Drivers & Expert-Curated Trade Recommendations - newser.com
Custom strategy builders for tracking DaVita Inc.IPO Watch & Free Weekly Chart Analysis and Trade Guides - newser.com
The Heart-Body Connection: How Other Organ Systems Affect Heart Health - GlobeNewswire Inc.
TD Cowen Adjusts Price Target on DaVita to $133 From $154 - MarketScreener
How to integrate DaVita Inc. into portfolio analysis tools2025 Trading Recap & Fast Exit and Entry Strategy Plans - newser.com
Is DaVita Trading at a Discount After 20.6% Drop in 2025? - Yahoo Finance
Is a relief rally coming for DaVita Inc. holdersTrade Exit Summary & Free Safe Entry Trade Signal Reports - newser.com
Can DaVita Inc. (TRL) stock attract ESG investmentsWeekly Loss Report & AI Driven Price Predictions - newser.com
Bessemer Group Inc. Sells 3,846 Shares of DaVita Inc. $DVA - MarketBeat
Will DaVita Inc. rebound enough to break even2025 Price Targets & Safe Entry Point Identification - newser.com
Is DaVita Inc. (TRL) stock safe for risk averse investorsJobs Report & Verified Momentum Stock Ideas - newser.com
DaVita (DVA): Exploring Current Valuation After Recent Share Price Pullback - Yahoo Finance
Can DaVita Inc. stock beat market expectations this quarterEarnings Beat & Stepwise Trade Signal Implementation - newser.com
Zacks Research Downgrades DaVita (NYSE:DVA) to Strong Sell - MarketBeat
Creekmur Asset Management LLC Sells 2,584 Shares of DaVita Inc. $DVA - MarketBeat
DaVita, Inc. Hits New 52-Week Low at USD 117.73 - Markets Mojo
Is DaVita Inc. stock bottoming outTrade Analysis Report & Daily Volume Surge Signals - newser.com
Will DaVita Inc. stock profit from fiscal stimulusStock Surge & Safe Swing Trade Setups - newser.com
Will DaVita Inc. stock outperform tech sector in 20252025 EndofYear Setup & Low Risk High Reward Ideas - newser.com
Is DaVita Inc. stock trading at a premium valuationWeekly Stock Recap & Daily Oversold Bounce Ideas - newser.com
Research Alert: CFRA Keeps Hold View On Shares Of Davita Inc. - 富途牛牛
DaVita (NYSE:DVA) Sets New 52-Week Low After Earnings Miss - MarketBeat
DaVita Inc. (DVA) Stock forecasts - Yahoo! Finance UK
DaVita (NYSE:DVA) Releases FY 2025 Earnings Guidance - MarketBeat
DaVita Inc. (DVA) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
DaVita Stock Down Post Q3 Earnings Miss Estimates, Revenues Up Y/Y - sharewise.com
DaVita Inc (DVA) Q3 2025 Earnings Call Highlights: Strong Financial Performance Amid Challenges By GuruFocus - Investing.com Canada
Berkshire Hathaway Reduces Stake in DaVita (DVA) by $54.3 Millio - GuruFocus
DaVita Inc. stock underperforms Thursday when compared to competitors - MarketWatch
DaVita (NYSE:DVA) Posts Earnings Results, Misses Expectations By $0.66 EPS - MarketBeat
DaVita Inc (DVA) Q3 2025 Earnings Call Highlights: Strong Financ - GuruFocus
Barclays Adjusts Price Target for DaVita (DVA), Maintains Equal-Weight Rating | DVA Stock News - GuruFocus
Barclays Adjusts Price Target on DaVita to $143 From $149 - MarketScreener
Deutsche Bank Adjusts Price Target on DaVita to $126 From $137 - MarketScreener
Davita Healthcare Partners stock hits 52-week low at $122.91 - Investing.com
Davita Healthcare Partners stock hits 52-week low at $122.91 By Investing.com - Investing.com Nigeria
DaVita price target lowered to $143 from $149 at Barclays - TipRanks
다비타 (DVA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):